Evidence map›Paper›PMID 33510837›Full record

ArticleOxidative medicine and cellular longevity2021

Ehretiquinone from

Yanjun Pan, Yanan Liu, Rui Fujii, Umer Farooq, Lihong Cheng, Akira Matsuura, Jianhua Qi, Lan Xiang

Open access · hybridAbstract read
In one paragraph

Article in Oxidative medicine and cellular longevity, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Gentirigeoside B fromAntioxidants (Basel, Switzerland) · 2022
    Article
  6. Review
  7. Exploration of targeted anti-tumor therapy · 2022
    Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 3 countries.

Yanjun PanCollege of Pharmaceutical Sciences, Zhejiang University, Yu Hang Tang Road 866, Hangzhou 310058, China.ORCID https://orcid.org/0000-0002-7786-1269
Yanan LiuCollege of Pharmaceutical Sciences, Zhejiang University, Yu Hang Tang Road 866, Hangzhou 310058, China.ORCID https://orcid.org/0000-0002-5139-2628
Rui FujiiDepartment of Biology, Graduate School of Science, Chiba University, Chiba 263-8522, Japan.ORCID https://orcid.org/0000-0002-2741-2027
Umer FarooqCollege of Pharmaceutical Sciences, Zhejiang University, Yu Hang Tang Road 866, Hangzhou 310058, China.ORCID https://orcid.org/0000-0001-7666-6982
Lihong ChengCollege of Pharmaceutical Sciences, Zhejiang University, Yu Hang Tang Road 866, Hangzhou 310058, China.ORCID https://orcid.org/0000-0002-2522-4831
Akira MatsuuraDepartment of Biology, Graduate School of Science, Chiba University, Chiba 263-8522, Japan.ORCID https://orcid.org/0000-0002-2300-7227
Jianhua QiCollege of Pharmaceutical Sciences, Zhejiang University, Yu Hang Tang Road 866, Hangzhou 310058, China.ORCID https://orcid.org/0000-0002-2723-1648
Lan XiangCollege of Pharmaceutical Sciences, Zhejiang University, Yu Hang Tang Road 866, Hangzhou 310058, China.ORCID https://orcid.org/0000-0001-6595-2836
Zhejiang University · CNChiba University · JPUniversity of Central Punjab · PK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The antiaging benzoquinone-type molecule ehretiquinone was isolated in a previous study as a leading compound from the herbal medicine

Indexed as

AnimalsAutophagyBenzoquinonesBoraginaceaeOxidative StressPC12 CellsRatsSaccharomyces cerevisiaeBenzoquinones

Identifiers

PMID33510837
PMCPMC7822689
OpenAlexW3119989816

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.